Patient Square Capital
Patient Square Capital is a dedicated healthcare investment firm built to deploy substantial and flexible capital across the healthcare ecosystem.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier I
Overview
Patient Square Capital is a dedicated healthcare investment firm built to deploy substantial and flexible capital across the healthcare ecosystem. Despite its relatively recent formation, the firm has developed approximately $19 billion in assets under management and participates in transactions requiring large-scale equity, sector knowledge, and long-duration support.
Its mandate spans established healthcare organizations, growth companies, products, services, and technologies. Patient Square has pursued major take-private and strategic transactions while emphasizing a patient-centered investment philosophy and the capital intensity required to support healthcare businesses through development, commercialization, and organizational transformation. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | Patient Square Capital |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | Menlo Park, United States |
| Founded | 2020 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier I |
Activities and investment capabilities
The firm’s team combines investment professionals with healthcare executives and sector specialists. This structure is relevant in a market where regulatory change, scientific complexity, care quality, and operating execution can materially affect investment outcomes.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
Patient Square fits Tier I because it has rapidly become one of the largest healthcare-only investment platforms. Its scale, transaction capability, sector breadth, and dedicated institutional model establish it as a leading force in contemporary healthcare private equity.
Patient Square Capital is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
Patient Square Capital is recognized Tier I in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Patient Square Capital’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Patient Square Capital as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Patient Square Capital |
| Headquarters | Menlo Park, United States |
| Public website | patientsquarecapital.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
